Infants with SCADD typically exhibit elevated C4 levels as the primary manifestation; 21 neonates diagnosed with SCADD in our study exhibited C4 levels significantly exceeding the normal range. This evidence concerns the gene C4A and short chain acyl-CoA dehydrogenase deficiency.